• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT.

作者信息

Singh S N, Cao Q, Gojo I, Rapoport A P, Akpek G

出版信息

Bone Marrow Transplant. 2012 Jul;47(7):1008-9. doi: 10.1038/bmt.2011.210. Epub 2011 Nov 14.

DOI:10.1038/bmt.2011.210
PMID:22080965
Abstract
摘要

相似文献

1
Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT.异基因造血干细胞移植后髓外复发的急性髓系白血病患者接受单药地西他滨治疗后获得持久完全缓解。
Bone Marrow Transplant. 2012 Jul;47(7):1008-9. doi: 10.1038/bmt.2011.210. Epub 2011 Nov 14.
2
Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT).地西他滨用于异基因造血干细胞移植（allo-SCT）后复发的急性髓系白血病（AML）患者。
Ann Hematol. 2013 Apr;92(4):549-50. doi: 10.1007/s00277-012-1607-y. Epub 2012 Oct 31.
3
Decitabine treatment for acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.
J Biol Regul Homeost Agents. 2017 Jan-Mar;31(1):171-175.
4
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.使用地西他滨和供者淋巴细胞输注治疗异基因干细胞移植后复发的急性髓系白血病和骨髓增生异常综合征——代表德国移植协作研究组的一项回顾性多中心分析
Ann Hematol. 2018 Feb;97(2):335-342. doi: 10.1007/s00277-017-3185-5. Epub 2017 Nov 18.
5
Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia.地西他滨治疗初诊及复发急性髓系白血病患者。
Leuk Lymphoma. 2013 Sep;54(9):2003-7. doi: 10.3109/10428194.2012.762093. Epub 2013 Feb 7.
6
A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.地西他滨与传统治疗用于急性髓系白血病完全缓解患者维持治疗的随机研究。
Leukemia. 2012 Nov;26(11):2428-31. doi: 10.1038/leu.2012.153. Epub 2012 Jun 5.
7
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.单药地西他滨治疗复发难治性急性髓系白血病的疗效
Leuk Lymphoma. 2017 Sep;58(9):1-7. doi: 10.1080/10428194.2017.1289524. Epub 2017 Feb 20.
8
A Case of Leukemia Cutis with Acute Myeloid Leukemia on Azacitidine Therapy.1例接受阿扎胞苷治疗的伴有急性髓系白血病的皮肤白血病病例。
Turk J Haematol. 2017 Jun 5;34(2):192-193. doi: 10.4274/tjh.2016.0220. Epub 2017 Feb 9.
9
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults.低剂量地西他滨治疗儿童和青年高危复发/难治性急性髓系白血病。
Br J Haematol. 2013 May;161(3):406-10. doi: 10.1111/bjh.12268. Epub 2013 Feb 23.
10
Studies of decitabine with allogeneic progenitor cell transplantation.地西他滨与异基因祖细胞移植的研究。
Leukemia. 1997 Mar;11 Suppl 1:S32-4.

引用本文的文献

1
Myeloid sarcoma: more and less than a distinct entity.骨髓肉瘤：不只是一个明确的实体。
Ann Hematol. 2023 Aug;102(8):1973-1984. doi: 10.1007/s00277-023-05288-1. Epub 2023 Jun 7.
2
Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology.儿童髓系肉瘤，不止是绿色瘤：临床表现、意义及生物学综述
Cancers (Basel). 2023 Feb 24;15(5):1443. doi: 10.3390/cancers15051443.
3
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.

本文引用的文献

1
5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.5-氮杂胞苷作为异基因骨髓移植后复发髓系肿瘤的挽救治疗。
Biol Blood Marrow Transplant. 2011 May;17(5):754-8. doi: 10.1016/j.bbmt.2010.10.008. Epub 2010 Oct 15.
2
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome.急性髓系白血病和骨髓增生异常综合征异基因干细胞移植后的髓外复发
Haematologica. 2010 Jun;95(6):860-3. doi: 10.3324/haematol.2010.025890.
3
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
阿扎胞苷与供体淋巴细胞输注用于急性髓系白血病及异基因造血干细胞移植后复发的骨髓增生异常综合征，供体为替代供者。
Ther Adv Hematol. 2022 Jun 17;13:20406207221090882. doi: 10.1177/20406207221090882. eCollection 2022.
4
Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma.118 例髓样肉瘤的临床特征、治疗和预后。
Sci Rep. 2022 Apr 26;12(1):6752. doi: 10.1038/s41598-022-10831-7.
5
Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.低剂量阿扎胞苷成功治疗老年骨髓增生异常综合征合并髓系肉瘤患者
Case Rep Hematol. 2021 Apr 21;2021:6640597. doi: 10.1155/2021/6640597. eCollection 2021.
6
Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes.去甲基化药物与免疫疗法：急性髓系白血病和骨髓增生异常综合征中的治疗协同作用
Front Oncol. 2021 Feb 25;11:624742. doi: 10.3389/fonc.2021.624742. eCollection 2021.
7
Long-Lasting Remission in De Novo Breast Myeloid Sarcoma Treated with Decitabine and Radiotherapy.地西他滨联合放疗治疗初诊乳腺髓系肉瘤的长期缓解
Diagnostics (Basel). 2019 Jul 27;9(3):84. doi: 10.3390/diagnostics9030084.
8
Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment.低剂量地西他滨通过重新调节肿瘤微环境增强微卫星稳定型结直肠癌中 PD-1 阻断的疗效。
Cell Mol Immunol. 2019 Apr;16(4):401-409. doi: 10.1038/s41423-018-0026-y. Epub 2018 Apr 5.
9
Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.用于异基因造血干细胞移植后治疗及预防复发的低甲基化药物。
Int J Hematol. 2018 Feb;107(2):138-150. doi: 10.1007/s12185-017-2364-4. Epub 2017 Nov 15.
10
An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review.骨髓纤维化后一种不寻常类型的髓系肉瘤定位：一例报告及文献复习
Leuk Res Rep. 2017 Jul 27;8:7-10. doi: 10.1016/j.lrr.2017.07.002. eCollection 2017.
急性白血病异基因干细胞移植后使用低剂量阿扎胞苷
Cancer. 2009 May 1;115(9):1899-905. doi: 10.1002/cncr.24198.
4
Graft-versus-leukemia effects of transplantation and donor lymphocytes.移植及供体淋巴细胞的移植物抗白血病效应
Blood. 2008 Dec 1;112(12):4371-83. doi: 10.1182/blood-2008-03-077974.
5
Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.使用阿扎胞苷成功治疗异基因干细胞移植后复发的急性髓系白血病。
Leuk Res. 2007 Feb;31(2):257-9. doi: 10.1016/j.leukres.2006.03.003. Epub 2006 Apr 18.
6
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.低剂量延长暴露方案的甲基化抑制剂5-氮杂-2'-脱氧胞苷（地西他滨）在血液系统恶性肿瘤中的1期研究。
Blood. 2004 Mar 1;103(5):1635-40. doi: 10.1182/blood-2003-03-0687. Epub 2003 Nov 6.
7
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.成人髓系母细胞的髓外肿瘤作为异基因骨髓移植后的一种复发模式。
Cancer. 1999 Feb 1;85(3):608-15. doi: 10.1002/(sici)1097-0142(19990201)85:3<608::aid-cncr11>3.0.co;2-5.